| Day Low 11:29 AM EDT | 12.61 | |
|---|---|---|
| Day High 09:30 AM EDT | 12.89 |
|
| Range | 0.28 | |
| Volume | 994,562 | |
| 30-Day Avg. Vol. | 709,000 |
|
| Difference | 40.28% | |
| Market Cap. | 2.05 B | |
| Change | 9.66 M | |
| Shares Out. | 161.02 M | |
| Percent Traded | 0.62% | |
| Revenue | — | |
| Earnings | — | |
| EPS (TTM) | 0.99 |
| 52-Wk Low 3/24/08 | 10.00 | |
|---|---|---|
| 52-Wk High 7/16/07 | 26.48 |
|
| Range | 16.48 | |
| Prev. Close 5/15/08 | 12.72 | |
| Today's Open | 12.82 | |
| Change | 0.79% | |
| Dividend (TTM) | — | |
| Div. Yield (TTM) | — |
|
| Beta | 1.25 | |
| P/E Ratio (TTM) | 12.91 | |
| P/E Ratio (Fwd.) | — |
Specialty pharmaceutical firm Biovail specializes in making improved versions of existing drugs using its oral drug delivery technologies, such as extended release and oral disintegration formulations. ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | — — | — — |
—
—
|
| Last Quarter | — — | — — |
—
—
|
| Quarterly - | Annual - | |
|---|---|---|
| Total Revenue | — | — |
| Gross Profit | — | — |
| Operating Income | — | — |
| Net Income | — | — |
